OMNIAB, INC. Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss
OMNIAB, INC. (OABI) had Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss of $20.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $20.00K.
- 2026-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $2.00K.
- 2025-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $0.00.
- 2025-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $1.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss |
|---|---|
| 2026-06-30 | $20.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $2.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $0.00 10-K · filed 2026-03-04 |
| 2025-09-30 | $1.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $4.00K 10-Q · filed 2025-08-06 |
| 2025-03-31 | $3.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $3.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $1.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $27.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $24.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $8.00K 10-K · filed 2025-03-18 |
| 2023-09-30 | $50.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $64.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $19.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $7.00K 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |